Age-related decrease in cerebrovascular-derived neuroprotective proteins: Effect of acetaminophen

Microvascular Research

Volumn 84, Issue 3, 2012, Pages 278-285

  Tripathy, Debjani ^a   Sanchez, Alma ^a   Yin, Xiangling ^a   Martinez, Joseph ^a   Grammas, Paula ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIRUDIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MENADIONE; NEUROPROTECTIVE AGENT; PARACETAMOL; PIGMENT EPITHELIUM DERIVED FACTOR; THROMBIN; VASCULOTROPIN;

ADULT ANIMAL; AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; IN VITRO STUDY; ISOLATED ORGAN; JUVENILE ANIMAL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; UPREGULATION;

ACETAMINOPHEN; AGING; ANALGESICS, NON-NARCOTIC; ANIMALS; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; MICROCIRCULATION; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, INBRED F344; SERPINS; THROMBIN; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84868128241     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.08.004     Document Type: Article

References (99)

1. Ahlskog J.E., Geda Y.E., Graff-Radford N.R., Petersen R.C. Physical exercise as a preventative or disease-modifying treatment of dementia and brain aging. Mayo Clin. Proc. 2011, 86:876-884.
2. Alba C., Vidal L., Diaz F., Villena A., de Vargas I.P. Ultrastructural and quantitative age-related changes in capillaries of the dorsal lateral geniculate nucleus. Brain Res. Bull. 2004, 64:145-153.
3. Arimura A., Somogyvari-Vigh A., Miyata A., Mizuno K., Coy D.H., Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 1991, 129:2787-2789.
4. Banks W.A., Kastin A.J. Aging and the blood-brain barrier changes in the carrier-mediated transport of peptides in rats. Neurosci. Lett. 1985, 61:171-175.
5. Barnstable C.J., Tombran-Tink J. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. Prog. Retin. Eye Res. 2004, 23:561-577.
6. Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009, 118:103-113.
7. Bierman A., Spector W., Atkins D., Basu J., Clancy C., Gross M., Lebbon A., Moody L., Rhoades J., Rothstein D., Sangl J., Schone B., Williams C. Improving the health and health care of older Americans: a report of the AHRQ task force on aging http://www.ahrq.gov/research/olderam/oldam1.htm.
8. Bisaglia M., Venezia V., Piccioli P., Stanzione S., Porcile C., Russo C., Mancini F., Milanese C., Schettini G. Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-kappaB activation. Neurochem. Int. 2002, 41:43-54.
9. Bishop N.A., Lu T., Yankner B.A. Neural mechanisms of ageing and cognitive decline. Nature 2010, 464:529-535.
10. Brown W.R., Thore C.R. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol. Appl. Neurobiol. 2011, 37:56-74.
11. Carmeliet P. Blood vessels and nerves: common signals, pathways and diseases. Nat. Rev. Genet. 2003, 4:710-720.
12. Cortese G.P., Barrientos R.M., Maier S.F., Patterson S.L. Aging and peripheral immune challenge interact to reduce mature brain-derived neurotrophic factor and activation of TrkB, PLC gamma1, and ERK in hippocampal synaptoneurosomes. J. Neurosci. 2011, 31:4274-4279.
13. de la Torre J.C. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004, 3:184-190.
14. de la Torre J.C. The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond. Neurodegener Dis 2010, 7:116-121.
15. Di Napoli M., Shah I.M. Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective. J. Aging Res. 2011, 857484.
16. Diglio C.A., Grammas P., Giacomelli F., Wiener J. Primary culture of rat cerebral microvascular endothelial cells. Isolation, growth and characterization. Lab. Invest. 1982, 46:554-563.
17. Diglio C.A., Liu W., Grammas P., Giacomelli F., Wiener J. Isolation and characterization of cerebral resistance vessel endothelium in culture. Tissue Cell 1993, 25:833-846.
18. Dupuy E., Habib A., Lebret M., Yang R., Levy-Toledano S., Tobelem G. Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1α. J. Thromb. Haemost. 2003, 1:1096-1102.
19. Farkas E., de Vos R.A., Donka G., Jansen Steur E.N., Mihaly A., Luiten P.G. Age-related microvascular degeneration in the human cerebral periventricular white matter. Acta Neuropathol. 2006, 111:150-157.
20. Festoff B.W., D'Andrea M.R., Citron B.A., Salcedo R.M., Smirnova I.V., Andrade-Gordon P. Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin. Mol. Med. 2000, 6:410-429.
21. Ganey P.E., Luyendyk J.P., Newport S.W., Eagle T.M., Maddox J.F., Mackman N., Roth R.A. Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology 2007, 46:1177-1186.
22. Gettins P.G., Simonovic M., Volz K. Pigment epithelium-derived factor (PEDF), a serpin with potent anti-angiogenic and neurite outgrowth-promoting properties. Biol. Chem. 2002, 383:1677-1682.
23. Gomez-Pinilla F., Vaynman S., Ying Z. Brain-derived neurotrophic factor functions as a metabotropin to mediate the effects of exercise on cognition. Eur. J. Neurosci. 2008, 28:2278-2287.
24. Gorelick P.B. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann. N. Y. Acad. Sci. 2010, 1207:155-162.
25. Grammas P. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J. Neuroinflammation 2011, 8:26.
26. Grammas P., Moore P., Weigel P.H. Microvessels from Alzheimer's disease brains kill neurons in vitro. Am. J. Pathol. 1999, 154:337-342.
27. Guo S., Lo E.H. Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke 2009, 40:S4-S7.
28. Guo S., Kim W.J., Lok J., Lee S.R., Besancon E., Luo B.H., Stins M.F., Wang X., Dedhar S., Lo E.H. Neuroprotection via matrix-tropic coupling between cerebral endothelial cells and neurons. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7582-7587.
29. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 2003, 60:1119-1122.
30. Helzner E.P., Luchsinger J.A., Scarmeas N., Cosentino S., Brickman A.M., Glymour M.M., Stern Y. Contribution of vascular risk factors to the progression in Alzheimer's disease. Arch. Neurol. 2009, 66:343-348.
31. Hofman A., Ott A., Breteler M.M., Bots M.L., Slooter A.J., van Harskamp F., van Duijn C.N., Van Broeckhoven C., Grobbee D.E. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997, 349:151-154.
32. Houenou L.J., D'Costa A.P., Li L., Turgeon V.L., Enyadike C., Alberdi E., Becerra S.P. Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J. Comp. Neurol. 1999, 412:6-514.
33. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 2004, 5:347-360.
34. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010, 120:287-296.
35. Ito Y., Bethea N.W., Abril E.R., McCuskey R.S. Early hepatic microvascular injury in response to acetaminophen toxicity. Microcirculation 2003, 10:391-400.
36. Jaeschke H., Knight T.R., Bajt M.L. The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicol. Lett. 2003, 144:279-288.
37. 2-induced injury in vivo. Exp. Biol. Med. 2008, 233:1315-1322.
38. Jin K.L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:10242-10247.
39. Jin K.L., Mao X.O., Batteur S.P., McEachron E., Leahy A., Greenberg D.A. Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience 2001, 108:351-358.
40. Kalaria R.N., Pax A.B. Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res. 1995, 705:349-352.
41. Kallmann B.A., Wagner S., Hummel V., Buttmann M., Bayas A., Tonn J.G., Rieckmann P. Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB J. 2002, 16:589-591.
42. Khaibullina A.A., Rosenstein J.M., Krum J.M. Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures. Brain Res. Dev. Brain Res. 2004, 148:59-68.
43. Kim H., Li Q., Hempstead B.L., Madri J.A. Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J. Biol. Chem. 2004, 279:33538-33546.
44. Kis B., Snipes J.A., Isse T., Nagy K., Busija D.W. Putative cyclooxygenase-3 expression in rat brain cells. J. Cereb. Blood Flow Metab. 2003, 23:1287-1292.
45. Latimer C.S., Searcy J.L., Bridges M.T., Brewer L.D., Popovic J., Blalock E.M., Landfield P.W., Thibault O., Porter N.M. Reversal of glial and neurovascular markers of unhealthy brain aging by exercise in middle-aged female mice. PLoS One 2011, 6:e26812.
46. Lau Y.S., Patki G., Das-Panja K., Le W.D., Ahmad S.O. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration. Eur. J. Neurosci. 2011, 33:1264-1274.
47. Lei X.G., Zhu J.H., McClung J.P., Aregullin M., Roneker C.A. Mice deficient in Cu, Zn-superoxide dismutase are resistant to acetaminophen toxicity. Biochem. J. 2006, 399:455-461.
48. Liu Z.X., Kaplowitz N. Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin. Drug Metab. Toxicol. 2006, 2:493-503.
49. Locke C.J., Fox S.A., Caldwell G.A., Caldwell K.A. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease. Neurosci. Lett. 2008, 439:129-133.
50. Lucas R., Warner T.D., Vojnovic I., Mitchell J.A. Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. FASEB J. 2005, 19:635-637.
51. Maharaj H., Maharaj D.S., Daya S. Acetylsalicylic acid and acetaminophen protect against oxidative neurotoxicity. Metab. Brain Dis. 2006, 21:189-199.
52. Mancini F., Landolfi C., Muzio M., Aquilini L., Soldo L., Coletta I., Guglielmotti A., Mantovanni A., Pinza M., Milanese C. Acetaminophen down-regulates interleukin-1β-induced nuclear factor-k{cyrillic}B nuclear translocation in a human astrocytic cell line. Neurosci. Lett. 2003, 353:79-82.
53. Maragoudakis M.E., Tsopanoglou N.E., Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochem. Soc. Trans. 2002, 30:173-177.
54. Matsuzaki H., Tamatani M., Yamaguchi A., Namikawa K., Kiyama H., Vitek M.P., Mitsuda N., Tohyama M. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J. 2001, 15:1218-1220.
55. Mhatre M., Nguyen A., Pham T., Adesina A., Grammas P. Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol. Aging 2004, 25:783-793.
56. Miller J.W. Homocysteine and Alzheimer's disease. Nutr. Rev. 1999, 57:126-129.
57. Mooradian A.D. Blood-brain barrier transport of choline is reduces in the aged rat. Brain Res. 1988, 440:328-332.
58. Mooradian A.D. Potential mechanisms of the age-related changes in the blood-brain barrier. Neurobiol. Aging 1994, 15:751-755.
59. Naldini A., Carney D.H., Pucci A., Pasquali A., Carraro F. Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1. Gen. Pharmacol. 2000, 35:255-259.
60. Navaratna D., Guo S., Hayakawa K., Wang X., Gerhardinger C., Lo E.H. Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes 2011, 60:1789-1796.
61. Nencini C., Giorgi G., Micheli L. Protective effect of silymarin on oxidative stress in rat brain. Phytomedicine 2007, 14:129-135.
62. Olaleye M.T., Rocha B.T. Acetaminophen-induced liver damage in mice: effects of some medicinal plants on the oxidative defense system. Exp. Toxicol. Pathol. 2008, 59:319-327.
63. Olszewska-Pazdrak B., Hart-Vantassell A., Carney D.H. Thrombin peptide TP508 stimulates rapid nitric oxide production in human endothelial cells. J. Vasc. Res. 2010, 47:203-213.
64. Onoue S., Endo K., Ohshima K., Yajima T., Kashimoto K. The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells. Peptides 2002, 23:1471-1478.
65. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Collen D., Carmeliet P., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., Carmeliet P. Deletion of hypoxia-response in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 2001, 28:131-138.
66. Pansari K., Gupta A., Thomas P. Alzheimer's disease and vascular factors: facts and theories. Int. J. Clin. Pract. 2002, 56:197-203.
67. Price J.M., Hellermann A., Hellermann G., Sutton E.T. Aging enhances vascular dysfunction induced by the Alzheimer's beta-amyloid. Neurol. Res. 2004, 26:305-311.
68. Reglodi D., Tamas A., Somogyvari-Vigh A., Szanto Z., Kertes E., Lenard L., Arimura A., Lengvari I. Effects of pretreament with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides 2002, 23:2227-2234.
69. Reimann-Philipp U., Ovase R., Weigel P.H., Grammas P. Mechanisms of cell death in primary cortical neurons and PC12 cells. J. Neurosci. Res. 2001, 64:654-660.
70. Rhodin J.A., Thomas T. A vascular connection to Alzheimer's disease. Microcirculation 2001, 8:207-220.
71. Sanagi T., Yabe T., Yamada H. Gene transfer of PEDF attenuates ischemic brain damage in the rat middle cerebral artery occlusion model. J. Neurochem. 2008, 106:1841-1854.
72. Sanchez A., Chiriva-Internati M., Grammas P. Transduction of PACAP38 protects primary cortical neurons from neurotoxic injury. Neurosci. Lett. 2008, 448:52-55.
73. Sanchez A., Rao H.V., Grammas P. PACAP38 protects rat cortical neurons against the neurotoxicity evoked by sodium nitroprusside and thrombin. Regul. Pept. 2009, 152:33-40.
74. Sanchez A., Wadhwani S., Grammas P. Multiple neurotrophic effects of VEGF on cultured neurons. Neuropeptides 2010, 44:323-331.
75. Sanchez A., Tripathy D., Yin X., Luo J., Martinez J., Grammas P. Pigment epithelium-derived factor (PEDF) protects cortical neurons in vitro from oxidant injury by activation of extracellular signal-regulated kinase (ERK)1/2 and induction of Bcl-2. Neurosci. Res. 2012, 72:1-8.
76. Schmidt R., Schmidt H., Fazekas F. Vascular risk factors in dementia. J. Neurol. 2000, 247:81-87.
77. Schneider J.A., Bennett D.A. Where vascular meets neurodegenerative disease. Stroke 2010, 41:S144-S146.
78. Schnitzer J.E. Vascular targeting as a strategy for cancer. N. Engl. J. Med. 1998, 339:472-474.
79. Seabrook T.J., Littlewood-Evans A., Brinkmann V., Pollinger B., Schnell C., Hiestand P.C. Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions. J. Neuroinflammation 2010, 7:95.
80. Shintani N., Suetake S., Hashimoto H., Koga K., Kasai A., Kawaguchi C., Morita Y., Hirose M., Sakai Y., Tomimoto S., Matsuda T., Baba A. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons. Regul. Pept. 2005, 126:123-128.
81. Sköld M.K., Kanje M. Vascular endothelial growth factor in central nervous system injuries-a vascular growth factor getting nervous?. Curr. Neurovasc. Res. 2008, 5:246-259.
82. Smirnova I.V., Citron B.A., Arnold P.M., Festoff B.W. Neuroprotective signal transduction in model motor neurons exposed to thrombin: G-protein modulation effects on neurite outgrowth, Ca(2+) mobilization, and apoptosis. J. Neurobiol. 2001, 48:87-100.
83. Somogyvari-Vigh A., Reglodi D. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr. Pharm. Des. 2004, 10:2861-2889.
84. Sondell M., Sundler F., Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci. 2000, 12:4243-4254.
85. Sparkenbaugh E.M., Saini Y., Greenwood K.K., LaPres J.J., Luyendyk J.P., Copple B.L., Maddox J.F., Ganey P.E., Roth R.A. The role of hypoxia-inducible factor-1α in acetaminophen hepatotoxicity. J. Pharmacol. Exp. Ther. 2011, 338:492-502.
86. Sparks D.L., Hunsaker J.C., Scheff S.W., Kryscio R.J., Henson J.L., Markesbery W.R. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol. Aging 1990, 11:601-607.
87. Striggow F., Riek M., Breder J., Henrich-Noack P., Reymann K.G., Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2264-2269.
88. Tarkowski E., Issa R., Sjogren M., Wallin A., Blennow K., Tarkowski A., Kumar P. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol. Aging 2002, 23:237-243.
89. Tripathy D., Grammas P. Acetaminophen protects brain endothelial cells against oxidative stress. Microvasc. Res. 2009, 77:289.
90. Tripathy D., Yin X., Sanchez A., Luo J., Martinez J., Grammas P. Cerebrovascular expression of proteins related to inflammation, oxidative stress and neurotoxicity is altered with aging. J. Neuroinflammation 2010, 7:63.
91. Uspenskaia O., Liebetrau M., Herms J., Danek A., Hamann G.F. Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels. BMC Neurosci. 2004, 5:37.
92. Van Kirk C.A., VanGuilder H.D., Young M., Farley J.A., Sonntag W.E., Freeman W.M. Age-related alteration in retinal neurovascular and inflammatory transcripts. Mol. Vis. 2011, 17:1261-1274.
93. Vasilevko V., Passos G.F., Quiring D., Head E., Kim R.C., Fisher M., Cribbs D.H. Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy. Ann. N. Y. Acad. Sci. 2010, 1207:58-70.
94. Vaughan P.J., Pike C.J., Cotman C.W., Cunningham D.D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 1995, 15:5389-5401.
95. Wang Y., Mao X.O., Xie L., Banwait S., Marti H.H., Greenber D.A., Jin K. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J. Neurosci. 2007, 27:304-307.
96. Warren M.C., Bump E.A., Medeiros D., Braunhut S.J. Oxidative stress-induced apoptosis of endothelial cells. Free Radic. Biol. Med. 2000, 29:537-547.
97. Williams C.D., Farhood A., Jaeschke H. Role of caspase-1 and interleukin-1 beta in acetaminophen-induced hepatic inflammation and liver injury. Toxicol. Appl. Pharmacol. 2010, 247:169-178.
98. Wu Z.L., Ciallella J.R., Flood D.G., O'Kane T.M., Bozyczko-Coyne D., Savage M.J. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Neurobiol. Aging 2006, 27:377-386.
99. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.